|
|
||||||||
Eur J Cardiothorac Surg 1999;15:742-746
© 1999 Elsevier Science NL
a Department of Paediatric Cardiology, Royal Brompton Hospital, Imperial College of Science, Technology and Medicine, London, UK
b Department of Cardiac Surgery, Royal Brompton Hospital, Imperial College of Science, Technology and Medicine, London, UK
c Department of Anaesthesia, Royal Brompton Hospital, Imperial College of Science, Technology and Medicine, London, UK
Received 26 October 1998; received in revised form 15 February 1999; accepted 11 March 1999.
Corresponding author. Royal Brompton Hospital, Sydney Street, Chelsea, London SW3 6NP, UK. Tel.: +44-171-351-8546; fax: +44-171-351-8545
e-mail: reding{at}ibm.net
| Abstract |
|---|
|
|
|---|
, time constant of isovolumic relaxation) indices of left ventricular function were measured. Results: Haemoconcentration was achieved in all modified ultrafiltration patients, median increase in haematocrit 34% (interquartile range 21%, 42%), final haematocrit 0.40 (0.35, 0.41). Ees increased 58% (9, 159, P=0.005). The changes in Eed, Pmax, Ped, dP/dtmax, dP/dtmin, and
were not significantly different from the control group. Conclusion: Modified ultrafiltration improves global left ventricular systolic function in infants and children following open-heart surgery.
Key Words: Congenital heart disease Cardiovascular surgery Ventricular function
| 1. Introduction |
|---|
|
|
|---|
In infants and children undergoing modified ultrafiltration (MUF) following corrective open-heart surgery we report an improvement in global left ventricular function, assessed from the pressurevolume plane using a conductance and microtip pressure catheter.
| 2. Methods |
|---|
|
|
|---|
2.2. Cardiopulmonary bypass and myocardial protection
All patients received a standardized protocol of isoflurane gaseous induction, pancuronium, fentanyl and isoflurane maintenance. They underwent bicaval and ascending aorta cannulation, and subsequently core cooling was begun on bypass to 2025°C. The priming solution was a mixture of whole blood and Hartmanns solution in a ratio calculated to achieve a haemoglobin concentration of 89 g/dl. Each patient received cold crystalloid cardioplegia (St. Thomas solution 1, 20 ml/kg) delivered by the perfusionist into the aortic root at 40 mmHg, after aortic cross-clamping. Cardiopulmonary bypass flow was 150 ml/kg per min (weight <10 kg) or 2.4 l/m2 per min (weight >10 kg). At the end of the procedure the cross-clamp was removed and rewarming begun on bypass. Ionized calcium was maintained at 1.0 mmol/l, boluses of calcium were given no closer than 20 min prior to the first set of post-cpb measurements and no calcium was given between measurements. All patients were in sinus rhythm and each patient remained on the same dose of dopamine (510 mg/kg per min) post-bypass and throughout the study period.
2.3. Modified ultrafiltration
Modified ultrafiltration was performed for 10 min within 510 min of cessation of bypass using the Great Ormond Street Hospital protocol [3] with a paediatric haemofilter (Paediatric Filtral 66, Gambro, Engstrom, Sweden). Flow through the filter was maintained at 200 ml/min by an inlet roller pump and outlet resistance varied to maintain a filtration rate of 100150 ml/min. The previously optimized left atrial pressure was maintained during filtration by transfusion from the venous reservoir through the filter. Filtration was performed for 10 min aiming to achieve a haemoglobin concentration of 12 g/dl. Blood was taken for measurement of haemoglobin concentration and haematocrit immediately before and after ultrafiltration.
2.4. Assessment of left ventricular function
The conductance catheter has been extensively validated for left ventricular volume measurement and details of the theory [12] and our customized conductance catheter system are presented elsewhere [13,14]. Left ventricular function was assessed with the chest and pericardium widely open and ventilation stopped at end-expiration, initially 510 min after coming off cardiopulmonary bypass and then repeated after a further 10 min with or without (controls) an intervening period of modified ultrafiltration. Real-time left ventricular pressurevolume loops were generated using conductance catheter and microtip pressure catheter (2F, Millar) inserted through the left ventricular apex and secured with a pledget and purse-string suture. The conductance catheters were custom built (NuMed Inc., Hopkinton, NY) single-field 3F (interelectrode distance 0.360.50 cm) or 5F (interelectrode distance 0.71 cm) catheters with eight platinum ring electrodes. Conductance catheters of the appropriate size were selected based on the measured left ventricular long axis from the parasternal long-axis view of the pre-operative echocardiogram. The conductance catheter was manipulated until all five segmental volumes were in-phase and a counter-clockwise rotating pressurevolume loop was formed demonstrating that the conductance catheter was not in the left atrium or aorta, and therefore must lie within the long-axis of the left ventricle. Preload was varied by transient (10 s) snaring of the inferior caval vein. All volume measurements were corrected for blood resistivity and parallel conductance, and each was determined before and after ultrafiltration. Parallel conductance was determined by the hypertonic saline method [12] using an injection of 0.52.5 ml of 20% NaCl into the pulmonary artery. Once a stable position with good quality pressurevolume loops was found there was no further catheter manipulation, and the dimensionless gain constant alpha was assumed to be unity and unchanged during the study period.
The conductance catheter signal encoding volume and ECG data were fed to a stimulator/processor unit (Sigma -5-DF, Cardiodynamics) and then to a committed microcomputer, where it was integrated with the amplified pressure signals (Fylde Isotransducer Amplifier) in custom designed software.
2.5. Data analysis
The end-systolic and end-diastolic pressurevolume relationships were derived from left ventricular pressurevolume loops generated under varying preload. Since the pericardium was widely opened and preload was varied over only a limited range, the end-diastolic pressurevolume relationship was fitted with a straight line. Linear regression estimations of the end-systolic and end-diastolic pressurevolume relationships were excluded if R2<0.5. Load-dependent indices were also obtained from steady-state microtip pressure recordings: peak systolic pressure (Pmax), left ventricular end-diastolic pressure (Ped), tau (
), the time constant of isovolumic relaxation; dP/dtmax and dP/dtmin. Percentage change in each index of ventricular function was calculated for each patient (pre-MUF compared to post-MUF, post-bypass compared to post-bypass+10 min for controls). The change in ventricular function in the ultrafiltration group was compared with that of the control group using the MannWhitney rank sum test. The null hypothesis was rejected if P<0.05 (corrected for ties). Results are presented as median (interquartile range, IQR).
| 3. Results (see Table 1) |
|---|
|
|
|---|
) for the MUF group were not significantly different from controls (Fig. 1)
.
|
|
| 4. Discussion |
|---|
|
|
|---|
A recent study in 21 infants suggested MUF improved left ventricular function based on changes in pressuredimension loops i.e global left ventricular function was inferred from changes in a single minor-axis chord [1]. Extrapolating global chamber changes from the behaviour of a single chord is potentially misleading, but is particularly problematic in the immediate post-bypass period when incoordinate wall motion is frequently encountered. Indeed our group has previously demonstrated that M-mode derived indices of ventricular function are critically dependent on the axis examined [16]. The small decrease in end-diastolic pressure, wall thickness, wall area and increase in minor axis length were interpreted as reflecting an increase in compliance. Standard indices of diastolic function such as time constant of isovolumic relaxation, dP/dtmin and the end-diastolic pressurevolume relationship were not reported and hence assessment of diastolic function was indirect.
4.1. Effect of ultrafiltration on cytokines
Ultrafiltration can potentially ameliorate increased total body water and inflammation following open-heart surgery. Although increased free water clearance whilst avoiding a hypercoagulable state seems worthwhile for overall post-operative management, most attention has focused on the effects of ultrafiltration on the inflammatory cascade.
Our group [16] and others [5,6,1719] have demonstrated ultrafiltration induced attenuation of the rise in cytokines (tumour necrosis factor
; interleukins 1, 6, 8 and 10), complement (C3a, C5a) and neutrophil degranulation in children undergoing open-heart surgery. The method of ultrafiltration (MUF versus conventional) only improved the clearance of tumour necrosis factor in one clinical study [19]. However, in a randomized study of conventional versus modified ultrafiltration in neonatal pigs, MUF was superior in terms of decreasing total body and cardiac weight gain, increasing systemic blood pressure and improving LV function as demonstrated by an increase in preload recruitable stroke work, although cytokine levels were not measured [4].
High-volume haemofiltration (median 4.97 l/m2) with no net fluid removal during rewarming, leads to lower cytokine levels immediately after haemofiltration and 24 h later, and reductions in postoperative blood loss, alveolararterial oxygen gradient, time to extubation compared to controls [6]. Immediately after haemofiltration tumour necrosis factor
, interleukin 10, C3a and myeloperoxidase were lower than controls whereas 24 h later interleukin 1, 6, 8 and myeloperoxidase were lower. The authors suggested that haemofiltration during rewarming, when cytokine levels usually rise, may have attenuated the inflammatory response. This study clearly shows that some effects of massive ultrafiltration are independent of free water clearance. However both the haemofiltration group and control group received modified ultrafiltration post-bypass, and so the effects of free water clearance could not be assessed.
Only one negative study of the effects of intraoperative haemofiltration has been published, and this was in a group of older children with median weight 17 kg [20]. Saatvedt et al. [20] reported 18 children with half randomized to receive ultrafiltration. Although 25 ml/kg fluid was removed there was no difference between the two groups in terms of haemodynamics, inflammatory mediator levels and post-operative course. The overall fluid balance for the first 24 h was no different between the two groups, largely because the ultrafiltration group required more colloid replacement as compared to controls in the intensive care unit, i.e. post-operatively they were forced to replace most of the fluid that had been removed by ultrafiltration intra-operatively. We have observed a similar high colloid requirement post-operatively, in some but not all patients that have undergone modified ultrafiltration.
The increase in Ees produced by modified ultrafiltration represents a moderate improvement in LV systolic function, approximately comparable to the effects of 45 mg/kg per min dopamine in a non-cardiopulmonary bypass animal model [21]. Although our results have added improvement in systolic LV function to the list of benefits of modified ultrafiltration, we caution against unequivocal acceptance of cytokine network manipulation by this technique prior to a large randomized trial. The more extensive experience of immunomodulatory therapies in sepsis has been disappointing, often initially encouraging at the small trial stage but when extended to larger populations have either failed or increased morbidity and mortality [22,23].
4.2. Conclusion
A significant increase in global left ventricular systolic function has been found in children undergoing modified ultrafiltration following open-heart surgery. This supports a previous analysis of the effects of ultrafiltration on left ventricular minor-axis function [1].
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Charette, Y. Hirata, A. Bograd, L. Mongero, J. Chen, J. Quaegebeur, and R. Mosca 180 ml and less: Cardiopulmonary bypass techniques to minimize hemodilution for neonates and small infants Perfusion, September 1, 2007; 22(5): 327 - 331. [Abstract] [PDF] |
||||
![]() |
S. G Raja, S. Yousufuddin, F. Rasool, A. Nubi, M. Danton, and J. Pollock Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rodriguez, M. Ruel, L. Broecker, and G. Cornel High Flow Rates During Modified Ultrafiltration Decrease Cerebral Blood Flow Velocity and Venous Oxygen Saturation in Infants Ann. Thorac. Surg., July 1, 2005; 80(1): 22 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, A. Hoschtitzky, M. L. Allen, M. J. Elliott, and A. N. Redington An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration Ann. Thorac. Surg., October 1, 2004; 78(4): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Luciani, T. Menon, B. Vecchi, S. Auriemma, and A. Mazzucco Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations: A Prospective, Randomized Clinical Trial Circulation, September 18, 2001; 104(90001): I-253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor Use of ultrafiltration during and after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 209 - 211. [Full Text] [PDF] |
||||
![]() |
S. T. Verghese Modified Ultrafiltration in Children Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 98 - 104. [Abstract] [PDF] |
||||
![]() |
P. D. Yorgin, A. Belson, and K. V. Lemley Continuous Renal Replacement Therapy in Neonates and Young Infants NeoReviews, September 1, 2000; 1(9): e163 - 172. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |